Comparative Pharmacology
Head-to-head clinical analysis: HALFLYTELY versus LAXILOSE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HALFLYTELY versus LAXILOSE.
HALFLYTELY vs LAXILOSE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PEG 3350 is an osmotic agent that causes water retention in the colon, leading to bowel evacuation. Electrolytes (sodium sulfate, potassium chloride, magnesium sulfate, sodium bicarbonate) prevent significant electrolyte shifts.
Laxilose (lactulose) is a synthetic disaccharide that is not absorbed in the small intestine. In the colon, it is metabolized by bacteria to short-chain fatty acids (e.g., lactic, acetic, formic acids), which osmotically draw water into the bowel lumen, stimulating peristalsis and softening stools. Additionally, in hepatic encephalopathy, colonic acidification traps ammonia (NH3) as ammonium (NH4+), reducing systemic ammonia absorption.
Oral: 1 liter (provided as powder for reconstitution) administered at a rate of 240 mL every 10 minutes until rectal effluent is clear or 4 liters total is consumed. Typically given as split-dose: half the volume the evening before and half the morning of colonoscopy.
10-20 g (15-30 mL) orally once daily; may increase to 40 g (60 mL) daily in divided doses.
None Documented
None Documented
Not applicable; PEG 3350 is not significantly absorbed and does not have a systemic half-life. The colon transit time is approximately 1 hour after ingestion.
Terminal elimination half-life is 2.5-4 hours in patients with normal renal function; prolonged to up to 20 hours in severe renal impairment.
Primarily fecal elimination of unabsorbed PEG 3350; negligible systemic absorption <0.06%. Electrolytes are excreted renally and fecally.
Primarily renal excretion, with approximately 40% of the dose recovered as unchanged drug in urine; biliary/fecal excretion accounts for the remainder, including metabolites.
Category C
Category C
Laxative
Laxative